News|Podcasts|February 10, 2025
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
Author(s)Miranda Schmalfuhs
Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.
Advertisement
In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, explores:
- How AI can potentially revolutionize patient engagement and adherence
- Utilizing patient-level data and predictive modeling
- How AI can identify individual needs and preferences
- The importance of ethical considerations and data privacy when leveraging AI in healthcare
- and more!
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
2
The Evolving Relationship Between FDA and Biotech
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
5